Szuchy Kristiansen Eva, Holm Vestergaard Hannah, Modrau Boris, Oppel Lorenz Martin
Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Department of Neurology, University Hospital, Aalborg, Denmark.
Case Rep Neurol. 2019 Feb 8;11(1):41-46. doi: 10.1159/000496084. eCollection 2019 Jan-Apr.
Pregnancy has usually been an exclusion criterion in clinical trials with thrombolysis and endovascular therapy in acute ischemic stroke. For that reason, these therapies are not recommended causing lack of evidence and vice versa. In this case report, we describe a pregnant woman in week 33 + 3 presenting with acute ischemic stroke, which was successfully treated with systemic thrombolysis and endovascular therapy, resulting in a good clinical outcome for both mother and child. The altered fibrinolytic system and the risk factors related to pregnancy constitute a challenge for clinicians when choosing the most suitable treatment modality for treating acute ischemic stroke in pregnancy. It is still uncertain whether thrombolysis in combination with endovascular therapy or endovascular therapy alone is the most appropriate treatment option. However, there is slowly growing evidence that thrombolysis and thrombectomy in pregnancy are feasible and safe with a good clinical outcome for both the mother and the child.
在急性缺血性卒中的溶栓和血管内治疗临床试验中,妊娠通常是一项排除标准。因此,由于缺乏证据,这些疗法不被推荐,反之亦然。在本病例报告中,我们描述了一名孕33 + 3周的孕妇出现急性缺血性卒中,经全身溶栓和血管内治疗成功治愈,母婴均获得良好的临床结局。纤溶系统的改变以及与妊娠相关的危险因素,给临床医生为妊娠期急性缺血性卒中选择最合适的治疗方式带来了挑战。溶栓联合血管内治疗还是单纯血管内治疗是最合适的治疗选择仍不确定。然而,越来越多的证据表明,妊娠期间进行溶栓和血栓切除术是可行且安全的,母婴均有良好的临床结局。